13188003: Tobramycin sulfate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Tobramycin sulfate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Tobramycin sulfate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Glycoside (substance)\Aminoglycoside (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Tobramycin sulfate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

22569012 Tobramycin sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

475103010 Tobramycin sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

736346012 Tobramycin sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

45031000188116 tobramycine sulfate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

846421000172118 sulfate de tobramycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tobramycin sulfate	Is a	Product containing tobramycin (medicinal product)	false	Inferred relationship	Some
Tobramycin sulfate	Is a	Bactericide	false	Inferred relationship	Some
Tobramycin sulfate	Is a	Tobramycin (substance)	false	Inferred relationship	Some
Tobramycin sulfate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Tobramycin (substance)	true	Inferred relationship	Some
Tobramycin sulfate	Is a	Substance with aminoglycoside structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Tobramycin sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Tobramycin sulfate 60mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tobramycin sulfate	Inferred relationship	Some
Tobramycin sulfate 80mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tobramycin sulfate	Inferred relationship	Some
Tobramycin sulfate 60mg/1 mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tobramycin sulfate	Inferred relationship	Some
Tobramycin sulfate 60mg/1 mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tobramycin sulfate	Inferred relationship	Some
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Tobramycin sulfate	Inferred relationship	Some	1
Product containing precisely tobramycin (as tobramycin sulfate) 80 milligram/2 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Tobramycin sulfate	Inferred relationship	Some	1
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Tobramycin sulfate	Inferred relationship	Some	1
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Tobramycin sulfate	Inferred relationship	Some	1
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and tobramycin (as tobramycin sulfate) 3 milligram/1 milliliter conventional release eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Tobramycin sulfate	Inferred relationship	Some	1

This concept is not in any reference sets